| Product Code: ETC6523257 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Overview |
3.1 Brunei Country Macro Economic Indicators |
3.2 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market - Industry Life Cycle |
3.4 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market - Porter's Five Forces |
3.5 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By ACE Inhibitors, 2021 & 2031F |
3.7 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic kidney disease in Brunei |
4.2.2 Growing awareness about the importance of managing mineral bone disorders in CKD patients |
4.2.3 Advancements in medical technology leading to better treatment options |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities in Brunei |
4.3.2 High cost associated with CKD-MBD treatment |
4.3.3 Lack of skilled healthcare professionals in the field of nephrology in Brunei |
5 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Trends |
6 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By Types |
6.1 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Medications And Supplements, 2021- 2031F |
6.1.4 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Dialysis, 2021- 2031F |
6.1.5 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Surgery, 2021- 2031F |
6.1.6 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Diet, 2021- 2031F |
6.1.7 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.1.8 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.2 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By ACE Inhibitors |
6.2.1 Overview and Analysis |
6.2.2 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By B-blockers, 2021- 2031F |
6.2.3 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Calcium Channel Blockers, 2021- 2031F |
6.2.4 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Loop Diuretics, 2021- 2031F |
6.2.5 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Erythropoiesis-Stimulating Agents (ESAs), 2021- 2031F |
6.2.6 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Phosphate Binders, 2021- 2031F |
6.2.7 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.3.4 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.3 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Ambulatory Surgical Centres, 2021- 2031F |
6.4.5 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.5.3 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.4 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.5 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.6 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Import-Export Trade Statistics |
7.1 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Export to Major Countries |
7.2 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Imports from Major Countries |
8 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Key Performance Indicators |
8.1 Average time to diagnosis of CKD-MBD patients in Brunei |
8.2 Rate of adherence to treatment regimens among CKD-MBD patients |
8.3 Percentage of CKD-MBD patients with controlled mineral bone disorders levels |
9 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market - Opportunity Assessment |
9.1 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By ACE Inhibitors, 2021 & 2031F |
9.3 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market - Competitive Landscape |
10.1 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenue Share, By Companies, 2024 |
10.2 Brunei Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here